Relative Incidence of Phlebitis Caused by Continuous Intravenous Infusion of Cephapirin and Cephalothin
Open Access
- 1 September 1972
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 2 (3), 234-235
- https://doi.org/10.1128/aac.2.3.234
Abstract
In a single-blinded study, two groups of 10 healthy subjects were given cephapirin or cephalothin by continuous intravenous infusion for 5 days, 0.5 g every 6 hr for the first day and then 1.0 g every 6 hr for 4 days. Eight of the cephalothin subjects and two of the cephapirin subjects developed phlebitis. Phlebitis was more severe in the cephalothin group and developed more rapidly, necessitating vein changes six times more often than in the cephapirin group. The less irritating properties of cephapirin demonstrated in this study indicate it may be the more useful cephalosporin analogue for intravenous therapy.Keywords
This publication has 8 references indexed in Scilit:
- Clinical and In Vitro Evaluation of Cephapirin, a New Cephalosporin AntibioticAntimicrobial Agents and Chemotherapy, 1972
- Clinical and in vitro evaluation of cephapirin: a new parenteral cephalosporinThe American Journal of the Medical Sciences, 1972
- Cephapirin: in vitro antibacterial spectrum.1971
- Cephapirin: clinical, pharmacological, and microbiological studies.1971
- Clinical manifestations of chancroid.1970
- Laboratory studies with a new cephalosporanic acid derivative.1969
- Treatment of Bacterial Endocarditis with CephalothinNew England Journal of Medicine, 1968
- Laboratory and Clinical Evaluation of a New Antibiotic—CephalothinAnnals of Internal Medicine, 1965